CHMP Endorses Moderna's (MRNA) mRNA-based RSV Vaccine

The CHMP's recommendation will now be reviewed by the European Commission (EC) and a final decision is expected shortly. If authorized, mResvia will be Moderna's second approved product in the region. The above news comes just a few days after Moderna suffered a major setback after the U.S. Centers for Disease Control and Prevention (CDC) revised their recommendation for the use of RSV vaccines for the upcoming respiratory virus season. This recommendation is based on data from data from the phase III Conqu ...